Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Brendel

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Nucleic Acids Research|January 22, 2015
A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cellsUta Müller-Kuller, Mania Ackermann, Stephan Kolodziej, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathiesBoya Liu, Christian Brendel, Divya S Vinjamur, et al.
Small Gtpases|January 5, 2022
Deletion of murine <i>Rhoh</i> leads to de-repression of <i>Bcl-6</i> via decreased KAISO levels and accelerates a malignancy phenotype in a murine model of lymphomaHiroto Horiguchi, Haiming Xu, Beatrice Duvert, et al.
Stem Cells (Dayton, Ohio)|January 12, 2013
A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progenyNils Pfaff, Nico Lachmann, Mania Ackermann, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell diseaseKevyn L Hart, Boya Liu, Devin Brown, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2012
Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicingKerstin B Kaufmann, Christian Brendel, Julia D Suerth, et al.
Human Gene Therapy Methods|March 16, 2013
Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapyChristian Brendel, Walther Hänseler, Vital Wohlgensinger, et al.
Oncogene|August 11, 2018
Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansionLinping Chen-Wichmann, Marina Shvartsman, Caro Preiss, et al.
Journal of Virology|June 15, 2012
Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicingSean Knight, Fang Zhang, Uta Mueller-Kuller, et al.
Blood|February 2, 2019
Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemiaShuqian Xu, Kevin Luk, Qiuming Yao, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Nucleic Acids Research|January 22, 2015
A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cellsUta Müller-Kuller, Mania Ackermann, Stephan Kolodziej, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathiesBoya Liu, Christian Brendel, Divya S Vinjamur, et al.
Small Gtpases|January 5, 2022
Deletion of murine <i>Rhoh</i> leads to de-repression of <i>Bcl-6</i> via decreased KAISO levels and accelerates a malignancy phenotype in a murine model of lymphomaHiroto Horiguchi, Haiming Xu, Beatrice Duvert, et al.
Stem Cells (Dayton, Ohio)|January 12, 2013
A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progenyNils Pfaff, Nico Lachmann, Mania Ackermann, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell diseaseKevyn L Hart, Boya Liu, Devin Brown, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2012
Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicingKerstin B Kaufmann, Christian Brendel, Julia D Suerth, et al.
Human Gene Therapy Methods|March 16, 2013
Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapyChristian Brendel, Walther Hänseler, Vital Wohlgensinger, et al.
Oncogene|August 11, 2018
Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansionLinping Chen-Wichmann, Marina Shvartsman, Caro Preiss, et al.
Journal of Virology|June 15, 2012
Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicingSean Knight, Fang Zhang, Uta Mueller-Kuller, et al.
Blood|February 2, 2019
Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemiaShuqian Xu, Kevin Luk, Qiuming Yao, et al.
Pageof 6